pharma · Acute Myeloid Leukemia · Breast Cancer
First People's Hospital
The First People's Hospital of Lianyungang
First People's Hospital clinical programs — 1136 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- SAN DIEGO, CA, CN
- Programs
- 1136
- Drugs
- 626
- Patents
- 123
First People's Hospital projects
1,136 ClinicalTrials.gov programs sponsored by First People's Hospital.
First People's Hospital has 1,136 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
KANG FU PEN
The First People's Hospital of Lianyungang
Cervical Cancer
1 trial -
Keverprazan
The First People's Hospital of Lianyungang
H. Pylori Infection
1 trial -
Lecanemab 10 mg/kg
The First People's Hospital of Lianyungang
Alzheimer s Disease
1 trial -
Levocarnitine Injection
The First People's Hospital of Lianyungang
Renal Dialysis
1 trial -
Levothyroxine
The First People's Hospital of Lianyungang
Heart Failure
1 trial -
Live Combined Bifidobacterium and Lactobacillus
The First People's Hospital of Lianyungang
Functional Constipation
1 trial -
Longidaza
The First People's Hospital of Lianyungang
Bacterial Vaginosis
1 trial -
Low dose Oliceridine
The First People's Hospital of Lianyungang
Oliceridine
1 trial -
Maggot debridement therapy
The First People's Hospital of Lianyungang
Diabetic Foot Ulcers
1 trial -
Mesalazine
The First People's Hospital of Lianyungang
Ulcerative Colitis, Unspecified
1 trial -
Methimazole
The First People's Hospital of Lianyungang
Graves Disease
1 trial -
Minocycline
The First People's Hospital of Lianyungang
Ischemic Stroke, Acute
2 trials -
Montelukast
The First People's Hospital of Lianyungang
Sinusitis
1 trial -
Nerve block with liposomal bupivacaine and intravenous analgesia
The First People's Hospital of Lianyungang
Liposomal Bupivacaine
1 trial -
Nifedipine GITS
The First People's Hospital of Lianyungang
Hypertension
1 trial -
Nocardia rubra Cell Wall Skeleton
The First People's Hospital of Lianyungang
Diabetic Foot Ulcer
1 trial -
OBU-BC-II-206
The First People's Hospital of Lianyungang
HER2 Positive Breast Cancer
1 trial -
Optimal hypoglycemic treatment
The First People's Hospital of Lianyungang
Type2 Diabetes
1 trial -
Ornithine aspartate granule
The First People's Hospital of Lianyungang
Non-alcoholic Fatty Liver Disease
1 trial -
PCIA group
The First People's Hospital of Lianyungang
Postoperative Pain
1 trial -
PEG-somatropin
The First People's Hospital of Lianyungang
Growth Hormone Deficiency
1 trial -
Parecoxib
The First People's Hospital of Lianyungang
Emergence Delirium
1 trial -
Parecoxib
The First People's Hospital of Lianyungang
Postoperative Pain Management, Pain Threshold, Shoulder Pain, Laparoscopies
1 trial -
Pegylated liposomal doxorubicin
The First People's Hospital of Lianyungang
Breast Cancer
1 trial -
Pharmacotherapy
The First People's Hospital of Lianyungang
Diabetes Mellitus, Type 2
1 trial -
Pramipexole
The First People's Hospital of Lianyungang
Restless Legs Syndrome
1 trial -
Prothrombin Complex Concentrate, Human
The First People's Hospital of Lianyungang
Cardiac Surgical Procedures
1 trial -
Raltitrexed
The First People's Hospital of Lianyungang
Head and Neck Squamous Cell Carcinoma
1 trial -
Realgar-Indigo Naturalis Formulation Combined with Anlotinib
The First People's Hospital of Lianyungang
Platinum-resistant Ovarian Cancer (PROC)
1 trial -
Recaticimab
The First People's Hospital of Lianyungang
STEMI - ST Elevation Myocardial Infarction
1 trial -
Recaticimab and Statin
The First People's Hospital of Lianyungang
Intracranial Atherosclerosis
1 trial -
Recombinant Human Adenovirus Type 5 injection
The First People's Hospital of Lianyungang
Hepatocellular Carcinoma
1 trial -
Recombinant Staphylokinase
The First People's Hospital of Lianyungang
Acute Myocardial Infarction
1 trial -
Recombinant Staphylokinase
The First People's Hospital of Lianyungang
ST-segment Elevation Myocardial Infarction (STEMI)
1 trial -
Recombinant staphylokinase
The First People's Hospital of Lianyungang
ST Elevation Myocardial Infarction
1 trial -
Remimazolam Besylate for Injection
The First People's Hospital of Lianyungang
Thoracic Surgery
1 trial -
Resveratrol
The First People's Hospital of Lianyungang
Pancreatitis, Acute
1 trial -
Rifaximin
The First People's Hospital of Lianyungang
IBS - Irritable Bowel Syndrome
1 trial -
Rituximab
The First People's Hospital of Lianyungang
Hemophagocytic Lymphohistiocytosis
1 trial -
Ropivacaine
The First People's Hospital of Lianyungang
Radius Fractures
1 trial -
Ropivacaine
The First People's Hospital of Lianyungang
End Stage Renal Disease (ESRD)
1 trial -
Rosuvastatin
The First People's Hospital of Lianyungang
Hyperlipidemia
1 trial -
Rucacuzumab plus standard therapy
The First People's Hospital of Lianyungang
Acute Ischemic Stroke AIS
1 trial -
Ruxolitinib
The First People's Hospital of Lianyungang
Safety and Efficacy
2 trials -
S-1
The First People's Hospital of Lianyungang
Pancreatic Cancer
1 trial -
S-ketamine & Ropivacaine
The First People's Hospital of Lianyungang
Postoperative Analgesia
1 trial -
SGLT2 inhibitor
The First People's Hospital of Lianyungang
Type2 Diabetes
1 trial -
SZ5202
The First People's Hospital of Lianyungang
Multiple Myeloma
1 trial
Frequently asked questions
How many clinical projects does First People's Hospital have?
1,136 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.